Cellular Identity Transitions in Chronic Tissue Fibrosis

69 concepts46 papers1 proposal

In healthy organs, epithelial and endothelial cells form highly organized, static barriers. They are anchored tightly to one another, maintaining tissue boundaries, protecting organs, and regulating vascular transport. However, under chronic stress, these cells can undergo a profound identity crisis. Instead of maintaining their specialized functions, they strip away their structural anchors, alter their morphology, and transform into mobile, matrix-secreting mesenchymal cells.

This process—known broadly as Epithelial-to-Mesenchymal Transition (EMT) or Endothelial-to-Mesenchymal Transition (EndMT)—is not merely a passive consequence of cell damage. It is an active, highly coordinated lineage reprogramming that turns protective structural cells into the primary drivers of pathological tissue scarring (fibrosis).

The Plasticity of Cellular Identity

When an organ is injured, resident fibroblasts typically migrate to the site to repair the damage. In chronic diseases, however, this localized response spirals out of control. As specialized barrier cells undergo EMT or EndMT, they become an abundant, endogenous source of myofibroblasts.

As explained by Caopei Zheng et al. in their review on pulmonary fibrosis, this transition turns structural cells into active orchestrators of a pro-fibrotic environment (Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis). These newly transformed cells flood the tissue matrix with excessive extracellular proteins like collagen. The result is a destructive cascade: organs stiffen, blood vessels leak, and functional tissue is permanently replaced by scar tissue.

This identity shift manifests across diverse pathologies:

Upstream Triggers: Stress, Metabolism, and Mechanotransduction

What forces a healthy, specialized cell to abandon its identity? The transition is initiated when external environmental stressors cross a threshold, forcing the cell to activate survival programs that inadvertently trigger reprogramming.

Mechanical Shear Stress

In vascular environments, physical forces dictate cell behavior. Qiaoyu Li et al. demonstrated that disturbed blood flow and oscillatory shear stress act as direct biological signals that recode the arterial lining (Single-cell RNA sequencing in atherosclerosis: Mechanism and precision medicine). This mechanotransduction process causes the endothelium to cease production of protective inhibitors and initiate inflammatory signaling. Similarly, Zhicheng Wang et al. highlighted how these mechanical stressors break down the valvular barrier, driving the early-stage tissue injury that leads to calcified aortic valve disease (Pathogenesis and Molecular Immune Mechanism of Calcified Aortic Valve Disease).

Organelle and Intracellular Stress

When cells experience metabolic overload or chronic injury, their internal machinery fails. Hui Zhao et al. established that endoplasmic reticulum (ER) stress serves as a primary trigger for EMT (Melatonin Inhibits Endoplasmic Reticulum Stress and Epithelial-Mesenchymal Transition during Bleomycin-Induced Pulmonary Fibrosis in Mice). When the ER is overwhelmed by misfolded proteins, it activates the Unfolded Protein Response (UPR).

As detailed by Caopei Zheng et al., this ER stress converges with mitochondrial dysfunction, releasing a torrent of reactive oxygen species (ROS) (Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis). These metabolic signals activate downstream inflammatory pathways, breaking the signaling chain that maintains normal tissue repair and locking the cell into a pro-fibrotic state.

[Disturbed Flow / Lipotoxicity / ER Stress]
                  │
                  ▼
     [Mitochondrial Dysfunction]
                  │
                  ▼
     [Reactive Oxygen Species (ROS)]
                  │
                  ▼
[Activation of Downstream EMT/EndMT Pathways]

The Intracellular Machinery and Epigenetic Rewiring

Once upstream stressors breach the cell's defenses, they activate core intracellular signaling pathways—such as the TGF-β/Smad3, PI3K/Akt, and NF-κB pathways—that systematically dismantle the cell's original genetic program. To understand why this transition works at a molecular level, we must look at how the cell's endogenous "brakes" are disabled.

Disabling the MicroRNA Brakes

In healthy tissue, small non-coding microRNAs (miRNAs) act as post-transcriptional gatekeepers, continuously silencing pro-fibrotic genes and preventing accidental transitions. Pathological signaling pathways work by systematically suppressing these microRNAs.

For example, Wei Qin et al. discovered that TGF-β/Smad3 signaling directly suppresses miR-29, a microRNA that normally prevents renal fibrosis (TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29). When miR-29 is depleted, the genetic brakes are released, allowing epithelial cells to transition and overproduce collagen.

Similarly, Fang Nie et al. identified miR-590 as an EMT-suppressive microRNA that directly targets and silences the TGFβ receptor 2 (TGFβR2) (MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathway). When chronic injury depletes miR-590, the cell loses its natural buffer against TGFβ, accelerating the shift toward a myofibroblast phenotype.

Epigenetic and Transcriptional Stabilization

Beyond microRNAs, the transition is stabilized by epigenetic modifications and non-coding RNAs that protect mesenchymal transcripts from degradation. Yuwei Wang et al. uncovered an epigenetic axis where the RNA-modifying enzyme METTL3 mediates the $m^6A$ methylation of HMGA2 mRNA (METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial–mesenchymal transition). This modification stabilizes the transcript, which in turn activates the master EMT transcription factor SNAIL, driving subretinal fibrosis.

In the microvascular stress of diabetic retinopathy, Xiao‐Lin Fu et al. demonstrated that a circular RNA, circZNF532, acts as a molecular bridge that recruits the protein TAF15 to stabilize PIK3CD mRNA (circZNF532 promotes endothelial-to-mesenchymal transition in diabetic retinopathy by recruiting TAF15 to stabilize PIK3CD). This stabilization triggers EndMT, resulting in vascular leakage and the formation of dysfunctional fibrous membranes.

Regulator Target / Mechanism Pathological Outcome
miR-29 Suppressed by TGF-β/Smad3 Renal Fibrosis
miR-590 Targets TGFβR2 (degraded in disease) Renal Epithelial Transition
METTL3 $m^6A$ modification stabilizes HMGA2 / activates SNAIL Subretinal Fibrosis
circZNF532 Recruits TAF15 to stabilize PIK3CD Diabetic Retinopathy

Therapeutic Strategies: Reversing the Identity Crisis

Because these cellular transitions rely on highly coordinated signaling networks rather than instantaneous damage, interrupting the cascade at key regulatory nodes offers a powerful strategy to halt or even reverse tissue scarring.

One therapeutic approach focuses on restoring the cell's natural regulatory brakes. Liulin Wang et al. demonstrated that the natural compound emodin can significantly reduce kidney scarring by boosting miR-490-3p, which silences the pro-fibrotic HMGA2 gene, effectively halting the progression of chronic kidney disease (Emodin ameliorates renal injury and fibrosis via regulating the miR-490-3p/HMGA2 axis).

Another strategy involves blocking the downstream intracellular pathways that execute the transition program:

By treating fibrosis not merely as an accumulation of excess collagen, but as a dynamic shift in cellular identity, these interventions aim to preserve the protective barriers of our organs before irreversible structural decay takes hold.

Key Foundational Work

A Generalized Framework for Pathosystems Informatics & Bioinformatics Web Services. (2007) — contributed 2 concept elements to this direction.
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29 (2011) — contributed 1 concept elements to this direction.
History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 46 papers
  2. Version 1 · 2026-10-04 · 23 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_endothelial_to_mesenchymal_transition_6eb05260,
  title = {endothelial-to-mesenchymal transition},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/endothelial-to-mesenchymal-transition/rdr_6eb052600751401b9103e611f762438e},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 2, frozen text):

@misc{lacuna_endothelial_to_mesenchymal_transition_6eb05260_v2,
  title = {endothelial-to-mesenchymal transition},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/endothelial-to-mesenchymal-transition/rdr_6eb052600751401b9103e611f762438e/v/2},
  note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake